Boston Scientific Corp. BSX
Analyst Ratings
- Consensus
- Buy — 20 Buy · 4 Hold · 0 Sell (24 analysts)
- Avg. Price Target
- $71.23 (+64.3% upside)
Key Stats
- Today's Range
- $43.05 – $43.90
- 50-Day Range
- $42.20 – $52.99
- 52-Week Range
- $42.20 – $109.50
- Volume
- 29.26 million shs
- Average Volume
- 20.53 million shs
- Market Cap
- $63.11 billion
- P/E Ratio
- 17.55
- Dividend Yield
- —
Valuation
- P/E Ratio
- 17.55
- Price / Book
- 2.51
- Price / Sales
- 3.01
Short Interest
- Short Interest
- 0.72%
- Days to Cover
- 1.67
Financials (TTM)
- Revenue
- $21.00 billion
- Net Income
- $3.67 billion
- Net Margin
- 17.47%
- Return on Equity
- 14.58%
- Debt-to-Equity
- —
About Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Related Stocks
Compare head-to-head: BSX vs SYK·BSX vs RMD·BSX vs BAX·BSX vs GMED
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.